查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1650481

2025 年吸入麻醉全球市场报告

Inhalation Anesthesia Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年吸入麻醉市场规模将强劲成长。到 2029 年，这一数字将成长至 23.4 亿美元，复合年增长率为 9.1%。预测期内的成长归因于对微创手术的需求增加、全球医疗保健支出的增加、新兴市场外科手术数量的增加、兽医学中吸入麻醉的采用以及政府对创新吸入麻醉剂研发的资金增加。预测期内的关键趋势包括麻醉输送系统的技术创新、儿科吸入麻醉设备的开发、向SEVOFLURANE和DESFLURANE的转变、对环境友善麻醉剂的关注以及麻醉输送中监测技术的整合。

预测期内老年人口的预期成长将推动吸入麻醉市场的发展。老龄人口的增加促进了吸入麻醉市场的扩大。这群人更容易患上退化性疾病疾病和慢性疾病，导致对手术和治疗性介入的需求增加。老年人口的不断增加对市场成长起到了关键作用，他们容易患心血管、神经、呼吸和退化性疾病等疾病。由于血管穿刺和患者依从性等问题，对老年患者经由静脉途径麻醉可能会不方便。例如，截至 2022 年 10 月，世界卫生组织 (WHO) 报告称，预计到 2022 年，全球 60 岁及以上人口将从 2020 年的 10 亿增加到 14 亿。此外，预计到2030年，全球六分之一的人口将超过60岁。因此，预计老年人口的成长将在整个预测期内推动对吸入麻醉剂的需求。

由于慢性病的增加，吸入麻醉市场预计将成长。慢性病的特征是持续超过三个月，需要手术介入诊断、治疗和管理。吸入麻醉对于在这些手术过程中提供患者的舒适和安全至关重要。根据美国国家医学图书馆2023年1月发布的报告，预计到2050年，患有一种或多种慢性病的50岁及以上人口数量将增加99.5%，从2020年的7152.2万人增加到1.4266亿人。因此，慢性病的增加预计将推动吸入麻醉市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、通膨、地缘政治、新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球吸入麻醉市场的 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球吸入麻醉市场成长率分析
  • 全球吸入麻醉市场表现：规模与成长，2019 年至 2024 年
  • 全球吸入麻醉市场预测：规模与成长，2024-2029 年，2034 年
  • 全球吸入麻醉总目标市场 (TAM)

第六章 市场细分

  • 全球吸入麻醉市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • SEVOFLURANE
  • DESFLURANE
  • Isoflurane
  • 氧化亚氮
  • 全球吸入麻醉市场的应用、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 麻醉诱导
  • 维护
  • 全球吸入麻醉市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 全球吸入麻醉市场：SEVOFLURANE按类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 液体
  • 气体形式
  • 全球吸入麻醉市场：DESFLURANE按类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 液体
  • 气体形式
  • 全球吸入麻醉市场：Isoflurane细分类型、表现和预测，2019-2024 年、2024-2029 年、2034 年
  • 液体
  • 气体形式
  • 全球吸入麻醉市场：氧化亚氮细分市场（按类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医用氧化亚氮
  • 工业氧化亚氮

第七章 区域和国家分析

  • 全球吸入麻醉市场：按地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球吸入麻醉市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

  • 吸入麻醉市场：竞争格局
  • 吸入麻醉市场：公司简介
    • Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Halocarbon Products Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • B. Braun Melsungen AG
  • Lunan Pharmaceutical Group Co. Ltd.
  • Maruishi Pharmaceutical Co. Ltd.
  • Mylan NV
  • Piramal Enterprises Ltd.
  • Recipharm AB
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt Ltd.
  • AstraZeneca PLC
  • CH Boehringer Sohn AG & Co. KG
  • Bristol-Myers Squibb Company
  • Eisai Co. Ltd.
  • GlaxoSmithKline PLC

第 32 章 全球竞争基准化分析与仪錶板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 吸入麻醉市场 2029-提供最多新机会的国家
  • 吸入麻醉市场 2029-提供最新兴机会的细分市场
  • 吸入麻醉市场 2029-成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第 36 章 附录

简介目录
Product Code: r21655

Inhalation anesthesia pertains to medications administered in operating rooms for the purpose of initiating and sustaining general anesthesia. Alongside other therapeutic effects, it induces varying degrees of drowsiness, ranging from mild to profound, ultimately achieving a state of general anesthesia. Inhalation anesthesia finds application in both the induction and maintenance phases of general anesthesia within the operating room.

Key products in the realm of inhalation anesthesia include sevoflurane, desflurane, isoflurane, and nitrous oxide. Isoflurane, specifically, is an inhaled general anesthetic employed for the initiation and upkeep of general anesthesia. Its action involves muscle relaxation and a reduction in pain sensitivity through the modification of tissue excitability. The uses of inhalation anesthesia encompass both the induction and maintenance phases, and the primary end-users are hospitals and ambulatory surgical centers.

The inhalation anesthesia market research report is one of a series of new reports from The Business Research Company that provides Inhalation anesthesia market statistics, including inhalation anesthesia industry global market size, regional shares, competitors with an inhalation anesthesia market share, detailed inhalation anesthesia market segments, market trends and opportunities, and any further data you may need to thrive in the inhalation anesthesia industry. This inhalation anesthesia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inhalation anesthesia market size has grown strongly in recent years. It will grow from $1.54 billion in 2024 to $1.65 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to growing surgical procedures requiring anesthesia, increased geriatric population, development of inhalation anesthetics, expansion of ambulatory surgical centers, increasing prevalence of chronic diseases such as heart disease and cancer.

The inhalation anesthesia market size is expected to see strong growth in the next few years. It will grow to $2.34 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rising demand for minimally invasive surgeries, growing global healthcare expenditure, increasing number of surgical procedures in emerging markets, adoption of inhalation anesthesia in veterinary medicine, increased government funds for r&d of innovative inhalation anesthetics. Major trends in the forecast period include technological innovations in anesthesia delivery systems, development of inhalation anesthesia devices for pediatric use, shift towards sevoflurane and desflurane, focus on eco-friendly anesthetic agents, integration of monitoring technologies in anesthesia delivery.

The anticipated growth in the geriatric population is set to drive the inhalation anesthesia market during the forecast period. The increasing number of elderly individuals contributes to the expansion of the inhalation anesthesia market as this demographic is more susceptible to degenerative diseases and chronic illnesses, leading to a heightened demand for surgeries and therapeutic interventions. The rise in the geriatric population, prone to ailments like cardiovascular, neurological, respiratory, and degenerative disorders, plays a significant role in boosting market growth. Administering anesthesia through an intravenous route to geriatric patients can be inconvenient due to issues with punctured blood vessels and patient compliance. For example, as of October 2022, the World Health Organization reports a projected global population of 1. 4 billion individuals aged 60 years by 2022 compared to 1 billion in 2020. Additionally, it is estimated that by 2030, one out of every six people worldwide will be aged 60 years or older. Consequently, the increasing geriatric population is expected to drive the demand for inhalation anesthesia throughout the forecast period.

The expected increase in chronic diseases is poised to fuel the growth of the inhalation anesthesia market. Chronic diseases, characterized by long-term persistence over three months or more, often necessitate surgical interventions for diagnosis, treatment, or management. Inhalation anesthesia becomes crucial in providing comfort and safety to patients during these surgical procedures. A report from the National Library of Medicine, published in January 2023, projects a 99. 5% increase in the number of individuals aged 50 years and older with one or more chronic illnesses, reaching 142. 66 million by 2050 in the United States, up from 71. 522 million in 2020. As a result, the upsurge in chronic diseases is expected to propel the growth of the inhalation anesthesia market.

In response to industry demands and to strengthen their market positions globally, numerous companies in the inhalation anesthesia sector are developing innovative products like Sedaconda. Sedaconda, an inhaled sedation therapy delivered through the Anaesthetic Conserving Device (ACD), received approval for use in intensive care. For example, in February 2022, Sedana Medical AB, a Sweden-based med-tech and pharmaceutical company, introduced Sedaconda (isoflurane) to the German market. Sedaconda (isoflurane) is administered using the medical device known as Sedaconda ACD (Anaesthetic Conserving Device) and is the sole approved inhaled sedation therapy authorized for use in intensive care settings.

Leading companies in the inhalation anesthesia market are channeling their efforts into developing innovative products such as end-tidal (ET) control software to enhance their offerings. The End-tidal (Et) Control software, designed for administering general anesthesia through the Aisys CS2 Anesthesia Delivery System, received FDA pre-market approval (PMA) from GE Healthcare Technologies Inc., a US-based medical technology company, in April 2022. This software facilitates semi-automated anesthesia administration by enabling anesthesia providers to set and maintain end-tidal oxygen and anesthetic agent targets, improving precision in inhalation anesthesia delivery, streamlining workflows, reducing drug wastage, and contributing to cost savings and reduced greenhouse gas emissions in healthcare settings.

In January 2022, Dechra Pharmaceuticals, a UK-based specialist veterinary pharmaceuticals and related products business, acquired Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant Anesthetic from Halocarbon Life Sciences for an undisclosed amount. This acquisition adds Isoflurane and Sevoflurane to Dechra's pharmaceutical companion animal portfolio, focusing on areas such as endocrinology, anesthesia, fluid therapy, dermatology, ophthalmology, pain management, joint health support, and dental care. Halocarbon Life Sciences is a US-based leader in supplying isoflurane and sevoflurane inhalation anesthetic products for human and veterinary applications.

Major companies operating in the inhalation anesthesia market include Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, B. Braun Melsungen AG, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co. Ltd., Mylan N. V., Piramal Enterprises Ltd., Recipharm AB, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Wockhardt Ltd., AstraZeneca PLC, C. H. Boehringer Sohn AG & Co. KG, Bristol-Myers Squibb Company, Eisai Co. Ltd., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi S. A., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, UCB S. A., Zydus Lifesciences Limited

North America was the largest region in the inhalation anesthesia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the inhalation anesthesia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The inhalation anesthesia market consists of sales of nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Inhalation Anesthesia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inhalation anesthesia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inhalation anesthesia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The inhalation anesthesia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Sevoflurane; Desflurane; Isoflurane; Nitrous Oxide
  • 2) By Application: Induction; Maintenance
  • 3) By End User: Hospitals; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Sevoflurane: Liquid Form; Gas Form
  • 2) By Desflurane: Liquid Form; Gas Form
  • 3) By Isoflurane: Liquid Form; Gas Form
  • 4) By Nitrous Oxide: Medical-Grade Nitrous Oxide; Industrial-Grade Nitrous Oxide
  • Companies Mentioned: Abbvie Inc.; Baxter International Inc.; Fresenius SE & Co. KGaA; Halocarbon Products Corporation; Hikma Pharmaceuticals PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Inhalation Anesthesia Market Characteristics

3. Inhalation Anesthesia Market Trends And Strategies

4. Inhalation Anesthesia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Inhalation Anesthesia Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Inhalation Anesthesia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Inhalation Anesthesia Market Growth Rate Analysis
  • 5.4. Global Inhalation Anesthesia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Inhalation Anesthesia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Inhalation Anesthesia Total Addressable Market (TAM)

6. Inhalation Anesthesia Market Segmentation

  • 6.1. Global Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide
  • 6.2. Global Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Induction
  • Maintenance
  • 6.3. Global Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • 6.4. Global Inhalation Anesthesia Market, Sub-Segmentation Of Sevoflurane,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Form
  • Gas Form
  • 6.5. Global Inhalation Anesthesia Market, Sub-Segmentation Of Desflurane,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Form
  • Gas Form
  • 6.6. Global Inhalation Anesthesia Market, Sub-Segmentation Of Isoflurane,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Form
  • Gas Form
  • 6.7. Global Inhalation Anesthesia Market, Sub-Segmentation Of Nitrous Oxide,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medical-Grade Nitrous Oxide
  • Industrial-Grade Nitrous Oxide

7. Inhalation Anesthesia Market Regional And Country Analysis

  • 7.1. Global Inhalation Anesthesia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Inhalation Anesthesia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Inhalation Anesthesia Market

  • 8.1. Asia-Pacific Inhalation Anesthesia Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Inhalation Anesthesia Market

  • 9.1. China Inhalation Anesthesia Market Overview
  • 9.2. China Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Inhalation Anesthesia Market

  • 10.1. India Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Inhalation Anesthesia Market

  • 11.1. Japan Inhalation Anesthesia Market Overview
  • 11.2. Japan Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Inhalation Anesthesia Market

  • 12.1. Australia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Inhalation Anesthesia Market

  • 13.1. Indonesia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Inhalation Anesthesia Market

  • 14.1. South Korea Inhalation Anesthesia Market Overview
  • 14.2. South Korea Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Inhalation Anesthesia Market

  • 15.1. Western Europe Inhalation Anesthesia Market Overview
  • 15.2. Western Europe Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Inhalation Anesthesia Market

  • 16.1. UK Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Inhalation Anesthesia Market

  • 17.1. Germany Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Inhalation Anesthesia Market

  • 18.1. France Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Inhalation Anesthesia Market

  • 19.1. Italy Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Inhalation Anesthesia Market

  • 20.1. Spain Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Inhalation Anesthesia Market

  • 21.1. Eastern Europe Inhalation Anesthesia Market Overview
  • 21.2. Eastern Europe Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Inhalation Anesthesia Market

  • 22.1. Russia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Inhalation Anesthesia Market

  • 23.1. North America Inhalation Anesthesia Market Overview
  • 23.2. North America Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Inhalation Anesthesia Market

  • 24.1. USA Inhalation Anesthesia Market Overview
  • 24.2. USA Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Inhalation Anesthesia Market

  • 25.1. Canada Inhalation Anesthesia Market Overview
  • 25.2. Canada Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Inhalation Anesthesia Market

  • 26.1. South America Inhalation Anesthesia Market Overview
  • 26.2. South America Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Inhalation Anesthesia Market

  • 27.1. Brazil Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Inhalation Anesthesia Market

  • 28.1. Middle East Inhalation Anesthesia Market Overview
  • 28.2. Middle East Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Inhalation Anesthesia Market

  • 29.1. Africa Inhalation Anesthesia Market Overview
  • 29.2. Africa Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Inhalation Anesthesia Market Competitive Landscape And Company Profiles

  • 30.1. Inhalation Anesthesia Market Competitive Landscape
  • 30.2. Inhalation Anesthesia Market Company Profiles
    • 30.2.1. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Halocarbon Products Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis

31. Inhalation Anesthesia Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Lunan Pharmaceutical Group Co. Ltd.
  • 31.3. Maruishi Pharmaceutical Co. Ltd.
  • 31.4. Mylan N. V.
  • 31.5. Piramal Enterprises Ltd.
  • 31.6. Recipharm AB
  • 31.7. Sandoz International GmbH
  • 31.8. Sun Pharmaceutical Industries Ltd.
  • 31.9. Teva Pharmaceutical Industries Ltd.
  • 31.10. Wockhardt Ltd.
  • 31.11. AstraZeneca PLC
  • 31.12. C. H. Boehringer Sohn AG & Co. KG
  • 31.13. Bristol-Myers Squibb Company
  • 31.14. Eisai Co. Ltd.
  • 31.15. GlaxoSmithKline PLC

32. Global Inhalation Anesthesia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Inhalation Anesthesia Market

34. Recent Developments In The Inhalation Anesthesia Market

35. Inhalation Anesthesia Market High Potential Countries, Segments and Strategies

  • 35.1 Inhalation Anesthesia Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Inhalation Anesthesia Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Inhalation Anesthesia Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer